LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 10

Search options

  1. Article ; Online: A review of genetic alterations in the serotonin pathway and their correlation with psychotic diseases and response to atypical antipsychotics.

    Baou, Maria / Boumba, Vassiliki A / Petrikis, Petros / Rallis, Georgios / Vougiouklakis, Theodore / Mavreas, Venetsanos

    Schizophrenia research

    2016  Volume 170, Issue 1, Page(s) 18–29

    Abstract: Serotonin is a neurotransmitter that plays a predominant role in mood regulation. The importance of the serotonin pathway in controlling behavior and mental status is well recognized. All the serotonin elements - serotonin receptors, serotonin ... ...

    Abstract Serotonin is a neurotransmitter that plays a predominant role in mood regulation. The importance of the serotonin pathway in controlling behavior and mental status is well recognized. All the serotonin elements - serotonin receptors, serotonin transporter, tryptophan hydroxylase and monoamine oxidase proteins - can show alterations in terms of mRNA or protein levels and protein sequence, in schizophrenia and bipolar disorder. Additionally, when examining the genes sequences of all serotonin elements, several single nucleotide polymorphisms (SNPs) have been found to be more prevalent in schizophrenic or bipolar patients than in healthy individuals. Several of these alterations have been associated either with different phenotypes between patients and healthy individuals or with the response of psychiatric patients to the treatment with atypical antipsychotics. The complex pattern of genetic diversity within the serotonin pathway hampers efforts to identify the key variations contributing to an individual's susceptibility to the disease. In this review article, we summarize all genetic alterations found across the serotonin pathway, we provide information on whether and how they affect schizophrenia or bipolar disorder phenotypes, and, on the contribution of familial relationships on their detection frequencies. Furthermore, we provide evidence on whether and how specific gene polymorphisms affect the outcome of schizophrenic or bipolar patients of different ethnic groups, in response to treatment with atypical antipsychotics. All data are discussed thoroughly, providing prospective for future studies.
    MeSH term(s) Antipsychotic Agents/therapeutic use ; Humans ; Psychotic Disorders/drug therapy ; Psychotic Disorders/genetics ; Receptors, Serotonin/genetics ; Serotonin/genetics
    Chemical Substances Antipsychotic Agents ; Receptors, Serotonin ; Serotonin (333DO1RDJY)
    Language English
    Publishing date 2016-01
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 639422-x
    ISSN 1573-2509 ; 0920-9964
    ISSN (online) 1573-2509
    ISSN 0920-9964
    DOI 10.1016/j.schres.2015.11.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: AU-rich RNA binding proteins in hematopoiesis and leukemogenesis.

    Baou, Maria / Norton, John D / Murphy, John J

    Blood

    2011  Volume 118, Issue 22, Page(s) 5732–5740

    Abstract: Posttranscriptional mechanisms are now widely acknowledged to play a central role in orchestrating gene-regulatory networks in hematopoietic cell growth, differentiation, and tumorigenesis. Although much attention has focused on microRNAs as regulators ... ...

    Abstract Posttranscriptional mechanisms are now widely acknowledged to play a central role in orchestrating gene-regulatory networks in hematopoietic cell growth, differentiation, and tumorigenesis. Although much attention has focused on microRNAs as regulators of mRNA stability/translation, recent data have highlighted the role of several diverse classes of AU-rich RNA-binding protein in the regulation of mRNA decay/stabilization. AU-rich elements are found in the 3'-untranslated region of many mRNAs that encode regulators of cell growth and survival, such as cytokines and onco/tumor-suppressor proteins. These are targeted by a burgeoning number of different RNA-binding proteins. Three distinct types of AU-rich RNA binding protein (ARE poly-U-binding degradation factor-1/AUF1, Hu antigen/HuR/HuA/ELAVL1, and the tristetraprolin/ZFP36 family of proteins) are essential for normal hematopoiesis. Together with 2 further AU-rich RNA-binding proteins, nucleolin and KHSRP/KSRP, the functions of these proteins are intimately associated with pathways that are dysregulated in various hematopoietic malignancies. Significantly, all of these AU-rich RNA-binding proteins function via an interconnected network that is integrated with microRNA functions. Studies of these diverse types of RNA binding protein are providing novel insight into gene-regulatory mechanisms in hematopoiesis in addition to offering new opportunities for developing mechanism-based targeted therapeutics in leukemia and lymphoma.
    MeSH term(s) ELAV Proteins/genetics ; ELAV Proteins/metabolism ; ELAV Proteins/physiology ; Gene Regulatory Networks/physiology ; Hematopoiesis/genetics ; Heterogeneous-Nuclear Ribonucleoprotein D/genetics ; Heterogeneous-Nuclear Ribonucleoprotein D/metabolism ; Heterogeneous-Nuclear Ribonucleoprotein D/physiology ; Humans ; Leukemia/genetics ; Leukemia/metabolism ; Leukemia/pathology ; Models, Biological ; RNA-Binding Proteins/genetics ; RNA-Binding Proteins/metabolism ; RNA-Binding Proteins/physiology ; Trans-Activators/genetics ; Trans-Activators/metabolism ; Trans-Activators/physiology
    Chemical Substances ELAV Proteins ; Heterogeneous-Nuclear Ribonucleoprotein D ; KHSRP protein, human ; RNA-Binding Proteins ; Trans-Activators
    Language English
    Publishing date 2011-09-13
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood-2011-07-347237
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: TIS11 family proteins and their roles in posttranscriptional gene regulation.

    Baou, Maria / Jewell, Andrew / Murphy, John J

    Journal of biomedicine & biotechnology

    2009  Volume 2009, Page(s) 634520

    Abstract: Posttranscriptional regulation of gene expression of mRNAs containing adenine-uridine rich elements (AREs) in their 3' untranslated regions is mediated by a number of different proteins that interact with these elements to either stabilise or destabilise ...

    Abstract Posttranscriptional regulation of gene expression of mRNAs containing adenine-uridine rich elements (AREs) in their 3' untranslated regions is mediated by a number of different proteins that interact with these elements to either stabilise or destabilise them. The present review concerns the TPA-inducible sequence 11 (TIS11) protein family, a small family of proteins, that appears to interact with ARE-containing mRNAs and promote their degradation. This family of proteins has been extensively studied in the past decade. Studies have focussed on determining their biochemical functions, identifying their target mRNAs, and determining their roles in cell functions and diseases.
    MeSH term(s) Animals ; Gene Expression Regulation ; Humans ; RNA Processing, Post-Transcriptional ; Tristetraprolin/chemistry ; Tristetraprolin/genetics ; Tristetraprolin/physiology
    Chemical Substances Tristetraprolin
    Language English
    Publishing date 2009-08-06
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2052552-7
    ISSN 1110-7251 ; 1110-7243
    ISSN (online) 1110-7251
    ISSN 1110-7243
    DOI 10.1155/2009/634520
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: TIS11 Family Proteins and Their Roles in Posttranscriptional Gene Regulation

    Maria Baou / Andrew Jewell / John J. Murphy

    Journal of Biomedicine and Biotechnology, Vol

    2009  Volume 2009

    Abstract: Posttranscriptional regulation of gene expression of mRNAs containing adenine-uridine rich elements (AREs) in their 3 untranslated regions is mediated by a number of different proteins that interact with these elements to either stabilise or destabilise ...

    Abstract Posttranscriptional regulation of gene expression of mRNAs containing adenine-uridine rich elements (AREs) in their 3 untranslated regions is mediated by a number of different proteins that interact with these elements to either stabilise or destabilise them. The present review concerns the TPA-inducible sequence 11 (TIS11) protein family, a small family of proteins, that appears to interact with ARE-containing mRNAs and promote their degradation. This family of proteins has been extensively studied in the past decade. Studies have focussed on determining their biochemical functions, identifying their target mRNAs, and determining their roles in cell functions and diseases.
    Keywords Biotechnology ; TP248.13-248.65 ; Chemical technology ; TP1-1185 ; Technology ; T ; DOAJ:Biotechnology ; DOAJ:Life Sciences ; DOAJ:Biology and Life Sciences
    Language English
    Publishing date 2009-01-01T00:00:00Z
    Publisher Hindawi Publishing Corporation
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article: Separate cell culture conditions to promote proliferation or quiescent cell survival in chronic lymphocytic leukemia.

    Willimott, Shaun / Baou, Maria / Huf, Sarah / Wagner, Simon D

    Leukemia & lymphoma

    2007  Volume 48, Issue 8, Page(s) 1647–1650

    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Animals ; Apoptosis ; Bone Marrow/metabolism ; Cell Cycle ; Cell Proliferation ; Cells, Cultured ; Fibroblasts/cytology ; Fibroblasts/metabolism ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Mesoderm/cytology ; Mesoderm/metabolism ; Mice ; Middle Aged ; Stromal Cells/cytology ; Stromal Cells/metabolism
    Language English
    Publishing date 2007-08-04
    Publishing country United States
    Document type Letter
    ZDB-ID 1042374-6
    ISSN 1029-2403 ; 1042-8194
    ISSN (online) 1029-2403
    ISSN 1042-8194
    DOI 10.1080/10428190701447353
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.

    Willimott, Shaun / Baou, Maria / Naresh, Kikkeri / Wagner, Simon D

    British journal of haematology

    2007  Volume 138, Issue 6, Page(s) 721–732

    Abstract: Chronic lymphocytic leukaemia cells survive and proliferate in patients but rapidly die in culture. The microenvironment that sustains leukaemic cells in vivo contains both stromal cell elements and T cells. We defined changes in Bcl-2 family protein ... ...

    Abstract Chronic lymphocytic leukaemia cells survive and proliferate in patients but rapidly die in culture. The microenvironment that sustains leukaemic cells in vivo contains both stromal cell elements and T cells. We defined changes in Bcl-2 family protein expression on culture with CD40 ligand (CD154) expressed on mouse fibroblast L cells, and interleukin-4 (IL-4; CD154/IL-4 system): conditions that support survival and proliferation. Unexpectedly, Bcl-2 protein expression decreased whilst pro-survival Bcl-x(L) (as well as A1 and Mcl-1) increased. However, the CD154-L cell/IL-4 system also increased the pro-apoptotic proteins, Bid and Noxa, suggesting that an increased pool of pro-survival factors and not the effects of a single protein mediate survival. Most pro-apoptotic proteins were not induced in drug or spontaneous apoptosis, but expression of Bcl-x(S), a pro-apoptotic BCL2L1 isoform, was associated with cell death. This was post-transcriptionally controlled, and, therefore, alternative splicing at the Bcl-x locus appears to have a role in the regulation of chronic lymphocytic leukaemia (CLL) cell survival. This study demonstrated a switch in pro-survival proteins associated with the transition from quiescence to CD154-driven proliferation. CLL therapies targeting Bcl-2 may need to be modified to antagonize proliferation centre-specific pro-survival proteins.
    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Apoptosis Regulatory Proteins/analysis ; Apoptosis Regulatory Proteins/metabolism ; BH3 Interacting Domain Death Agonist Protein/metabolism ; Blotting, Western ; CD40 Ligand/pharmacology ; Cell Proliferation ; Cell Survival ; Gene Expression ; Gene Expression Regulation, Neoplastic ; Humans ; Immunohistochemistry ; Interleukin-4/pharmacology ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell/metabolism ; Lymph Nodes/chemistry ; Mice ; Minor Histocompatibility Antigens ; Myeloid Cell Leukemia Sequence 1 Protein ; Neoplasm Proteins/analysis ; Neoplasm Proteins/metabolism ; Protein Kinase C/antagonists & inhibitors ; Proto-Oncogene Proteins/analysis ; Proto-Oncogene Proteins/metabolism ; Proto-Oncogene Proteins c-bcl-2/analysis ; Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Staurosporine/pharmacology ; Tumor Cells, Cultured ; Vidarabine/analogs & derivatives ; Vidarabine/pharmacology ; bcl-X Protein/analysis ; bcl-X Protein/metabolism
    Chemical Substances Antineoplastic Agents ; Apoptosis Regulatory Proteins ; BBC3 protein, human ; BCL2-related protein A1 ; BCL2L1 protein, human ; BH3 Interacting Domain Death Agonist Protein ; Mcl1 protein, mouse ; Minor Histocompatibility Antigens ; Myeloid Cell Leukemia Sequence 1 Protein ; Neoplasm Proteins ; PMAIP1 protein, human ; Proto-Oncogene Proteins ; Proto-Oncogene Proteins c-bcl-2 ; bcl-X Protein ; CD40 Ligand (147205-72-9) ; Interleukin-4 (207137-56-2) ; Protein Kinase C (EC 2.7.11.13) ; Vidarabine (FA2DM6879K) ; Staurosporine (H88EPA0A3N) ; fludarabine (P2K93U8740)
    Language English
    Publishing date 2007-09
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/j.1365-2141.2007.06717.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA.

    Nasir, Asghar / Norton, John D / Baou, Maria / Zekavati, Anna / Bijlmakers, Marie-Jose / Thompson, Steve / Murphy, John J

    PloS one

    2012  Volume 7, Issue 12, Page(s) e52187

    Abstract: The ZFP36/Tis11 family of zinc-finger proteins regulate cellular processes by binding to adenine uridine rich elements in the 3' untranslated regions of various mRNAs and promoting their degradation. We show here that ZFP36L1 expression is largely ... ...

    Abstract The ZFP36/Tis11 family of zinc-finger proteins regulate cellular processes by binding to adenine uridine rich elements in the 3' untranslated regions of various mRNAs and promoting their degradation. We show here that ZFP36L1 expression is largely extinguished during the transition from B cells to plasma cells, in a reciprocal pattern to that of ZFP36 and the plasma cell transcription factor, BLIMP1. Enforced expression of ZFP36L1 in the mouse BCL1 cell line blocked cytokine-induced differentiation while shRNA-mediated knock-down enhanced differentiation. Reconstruction of regulatory networks from microarray gene expression data using the ARACNe algorithm identified candidate mRNA targets for ZFP36L1 including BLIMP1. Genes that displayed down-regulation in plasma cells were significantly over-represented (P = <0.0001) in a set of previously validated ZFP36 targets suggesting that ZFP36L1 and ZFP36 target distinct sets of mRNAs during plasmacytoid differentiation. ShRNA-mediated knock-down of ZFP36L1 in BCL1 cells led to an increase in levels of BLIMP1 mRNA and protein, but not for mRNAs of other transcription factors that regulate plasmacytoid differentiation (xbp1, irf4, bcl6). Finally, ZFP36L1 significantly reduced the activity of a BLIMP1 3' untranslated region-driven luciferase reporter. Taken together, these findings suggest that ZFP36L1 negatively regulates plasmacytoid differentiation, at least in part, by targeting the expression of BLIMP1.
    MeSH term(s) Animals ; B-Lymphocytes/cytology ; B-Lymphocytes/metabolism ; Blotting, Western ; Butyrate Response Factor 1 ; Cell Differentiation/genetics ; Cell Differentiation/physiology ; Cell Line, Tumor ; Enzyme-Linked Immunosorbent Assay ; Mice ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; Positive Regulatory Domain I-Binding Factor 1 ; RNA, Messenger/genetics ; RNA, Small Interfering/genetics ; RNA-Binding Proteins/genetics ; RNA-Binding Proteins/metabolism ; Real-Time Polymerase Chain Reaction ; Reverse Transcriptase Polymerase Chain Reaction ; Transcription Factors/genetics
    Chemical Substances Butyrate Response Factor 1 ; Nuclear Proteins ; Prdm1 protein, mouse ; RNA, Messenger ; RNA, Small Interfering ; RNA-Binding Proteins ; Transcription Factors ; Zfp36l1 protein, mouse ; Positive Regulatory Domain I-Binding Factor 1 (EC 2.1.1.-)
    Language English
    Publishing date 2012-12-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0052187
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4.

    Willimott, Shaun / Baou, Maria / Huf, Sarah / Deaglio, Silvia / Wagner, Simon D

    Haematologica

    2007  Volume 92, Issue 10, Page(s) 1359–1366

    Abstract: Background and objectives: Chronic lymphocytic leukemia (CLL) cells, like normal B-cells, exist in two populations in vivo: quiescent cells in the peripheral circulation and proliferating cells in lymph nodes. The surface marker CD38 has roles in cell ... ...

    Abstract Background and objectives: Chronic lymphocytic leukemia (CLL) cells, like normal B-cells, exist in two populations in vivo: quiescent cells in the peripheral circulation and proliferating cells in lymph nodes. The surface marker CD38 has roles in cell adhesion and signaling. Its expression correlates with poor clinical outcome and is associated with expression of the signaling intermediate ZAP-70, which is also a marker of poor prognosis. We investigated the regulation of CD38 and ZAP-70 in proliferating CLL cells.
    Design and methods: We cultured CLL cells on a stromal cell layer that maintains viability and also with some stromal cells expressing CD40 ligand (CD154) in order to measure changes in expression of CD38 and ZAP-70.
    Results: We demonstrated up-regulation of CD38 expression by CD154. The degree of up-regulation did not correlate with clinical stage or mutational status. In addition in the majority of cases tested ZAP-70 expression increased in parallel with up-regulation of CD38 although discordant cases were also observed.
    Interpretation and conclusions: Overall we demonstrated that regulation of CD38 in CLL is dynamic and dependent on signals from CD154 and a stromal cell layer. We speculate that CD38 and ZAP-70 are expressed in lymph node leukemic cells in both good and poor prognosis patients, but, in cases with good clinical outcome, these molecules are down-regulated in the peripheral blood whereas in cases with poor prognosis their expression is maintained.
    MeSH term(s) ADP-ribosyl Cyclase 1/immunology ; ADP-ribosyl Cyclase 1/metabolism ; Antibodies/immunology ; CD40 Ligand/pharmacology ; Cell Proliferation/drug effects ; Humans ; Interleukin-4/pharmacology ; Leukemia, Lymphocytic, Chronic, B-Cell/metabolism ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Tumor Cells, Cultured ; ZAP-70 Protein-Tyrosine Kinase/metabolism
    Chemical Substances Antibodies ; CD40 Ligand (147205-72-9) ; Interleukin-4 (207137-56-2) ; ZAP-70 Protein-Tyrosine Kinase (EC 2.7.10.2) ; ADP-ribosyl Cyclase 1 (EC 3.2.2.6)
    Language English
    Publishing date 2007-10
    Publishing country Italy
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2333-4
    ISSN 1592-8721 ; 0017-6567 ; 0390-6078
    ISSN (online) 1592-8721
    ISSN 0017-6567 ; 0390-6078
    DOI 10.3324/haematol.11340
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA.

    Asghar Nasir / John D Norton / Maria Baou / Anna Zekavati / Marie-Jose Bijlmakers / Steve Thompson / John J Murphy

    PLoS ONE, Vol 7, Iss 12, p e

    2012  Volume 52187

    Abstract: The ZFP36/Tis11 family of zinc-finger proteins regulate cellular processes by binding to adenine uridine rich elements in the 3' untranslated regions of various mRNAs and promoting their degradation. We show here that ZFP36L1 expression is largely ... ...

    Abstract The ZFP36/Tis11 family of zinc-finger proteins regulate cellular processes by binding to adenine uridine rich elements in the 3' untranslated regions of various mRNAs and promoting their degradation. We show here that ZFP36L1 expression is largely extinguished during the transition from B cells to plasma cells, in a reciprocal pattern to that of ZFP36 and the plasma cell transcription factor, BLIMP1. Enforced expression of ZFP36L1 in the mouse BCL1 cell line blocked cytokine-induced differentiation while shRNA-mediated knock-down enhanced differentiation. Reconstruction of regulatory networks from microarray gene expression data using the ARACNe algorithm identified candidate mRNA targets for ZFP36L1 including BLIMP1. Genes that displayed down-regulation in plasma cells were significantly over-represented (P = <0.0001) in a set of previously validated ZFP36 targets suggesting that ZFP36L1 and ZFP36 target distinct sets of mRNAs during plasmacytoid differentiation. ShRNA-mediated knock-down of ZFP36L1 in BCL1 cells led to an increase in levels of BLIMP1 mRNA and protein, but not for mRNAs of other transcription factors that regulate plasmacytoid differentiation (xbp1, irf4, bcl6). Finally, ZFP36L1 significantly reduced the activity of a BLIMP1 3' untranslated region-driven luciferase reporter. Taken together, these findings suggest that ZFP36L1 negatively regulates plasmacytoid differentiation, at least in part, by targeting the expression of BLIMP1.
    Keywords Medicine ; R ; Science ; Q
    Subject code 570
    Language English
    Publishing date 2012-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells.

    Baou, Maria / Kohlhaas, Susan L / Butterworth, Michael / Vogler, Meike / Dinsdale, David / Walewska, Renata / Majid, Aneela / Eldering, Eric / Dyer, Martin J S / Cohen, Gerald M

    Haematologica

    2010  Volume 95, Issue 9, Page(s) 1510–1518

    Abstract: Background: Bortezomib has been successfully used in the treatment of multiple myeloma and has been proposed as a potential treatment for chronic lymphocytic leukemia. In this study we investigated the mechanism by which bortezomib induces apoptosis in ... ...

    Abstract Background: Bortezomib has been successfully used in the treatment of multiple myeloma and has been proposed as a potential treatment for chronic lymphocytic leukemia. In this study we investigated the mechanism by which bortezomib induces apoptosis in chronic lymphocytic leukemia cells.
    Design and methods: Using western blot analysis, we monitored the regulation of BCL2 family members, proteins of the unfolded protein response (endoplasmic reticulum stress response) and activation of caspases in relation to induction of apoptosis (measured by annexin-propidium iodide staining and loss of mitochondrial membrane potential) by bortezomib in chronic lymphocytic leukemia cells.
    Results: Bortezomib induced apoptosis through activation of the mitochondrial pathway independently of changes associated with endoplasmic reticulum stress. Perturbation of mitochondria was regulated by a rapid and transcription-independent increase of NOXA protein, which preceded release of cytochrome c, HtrA2, Smac and activation of caspase-9 and -3. NOXA had a short half life (approximately 1-2 h) and was ubiquitinated on at least three primary lysine residues, resulting in proteasomal-dependent degradation. Down-regulation of NOXA, using short interfering RNA in chronic lymphocytic leukemia cells, decreased bortezomib-induced apoptosis. Finally bortezomib when combined with seliciclib resulted in a stronger and earlier increase in NOXA protein, caspase-3 cleavage and induction of apoptosis in chronic lymphocytic leukemia cells.
    Conclusions: These results highlight a critical role for NOXA in bortezomib-induced apoptosis in chronic lymphocytic leukemia cells and suggest that this drug may become more efficient for the treatment of chronic lymphocytic leukemia if combined with other agents able to interfere with the basal levels of MCL1.
    MeSH term(s) Apoptosis/drug effects ; Boronic Acids/pharmacology ; Bortezomib ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/metabolism ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Protease Inhibitors/pharmacology ; Protease Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Proto-Oncogene Proteins c-bcl-2/physiology ; Pyrazines/pharmacology ; Tumor Cells, Cultured ; Ubiquitination
    Chemical Substances Boronic Acids ; PMAIP1 protein, human ; Protease Inhibitors ; Proto-Oncogene Proteins c-bcl-2 ; Pyrazines ; Bortezomib (69G8BD63PP)
    Language English
    Publishing date 2010-04-07
    Publishing country Italy
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2333-4
    ISSN 1592-8721 ; 0017-6567 ; 0390-6078
    ISSN (online) 1592-8721
    ISSN 0017-6567 ; 0390-6078
    DOI 10.3324/haematol.2010.022368
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top